Inventor
Lars Bärfacker
Inventor
Oberhausen, DE
Overview
Patents· 28 as inventor
Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.
A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds36%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds3%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium1%
PatentTitleYear
10,428,0443-amino-1,5,6,7-tetrahydro-4H-indol-4-ones201910,370,339N-Methylbenzimidazoles as mIDH1 inhibitors201910,350,206Benzyl substituted indazoles as BUB1 inhibitors201910,047,096Substituted pyridobenzodiazepinone-derivatives and use thereof20189,745,285'Heteroaryl substituted pyrazoles'20179,682,995'Amino-substituted isothiazoles'20179,604,989'Imidazopyridazines as Akt kinase inhibitors'20179,370,517'Substituted pyrazolopyrimidines as Akt kinase inhibitors'20169,260,435'Substituted imidazopyrazines as Akt kinase inhibitors'20169,216,978'Ring-fused pyrimidines and triazines and use thereof for the treatment and/or prophylaxis of cardiovascular diseases'20159,206,185'Imidazopyridazines as Akt kinase inhibitors'20159,096,592'Bicyclic aza heterocycles, and use thereof'20159,085,572'4-(pyridin-3-yl)-2(pyridin-2yl)-1,2-dihydro-3H-pyrazol-3-one derivatives as specific HIF-pyrolyl-4-hydroxylase inhibitors for treating cardiovascular and haematological diseases'20159,051,316'Substituted 4-aryl-1,4-dihydro-1,6-naphthyridine amides and their use'20158,436,180'Substituted-4-aryl-1,4-dihydro-1,6-naphthyridinamides and use thereof'20138,404,723'3-cyano 5-thiazaheteroaryl-dihydropyridine and the use thereof for the treatment of cardiovascular diseases'20138,404,709'Substituted 4-aryl-1,4-dihydro-1,6-naphthyridines and use thereof'20138,399,471'Aryl-or heteroaryl-substituted pyrido[2,3-d] pyrimidines and pharmaceutical compositions of the same'20138,324,222'Cyclically substituted furopyrimidine derivatives and use thereof'20128,252,817'Dipyridyl-dihydropyrazolones and their use'20128,183,246'Acyclically substituted furopyrimidine derivatives and use thereof'20128,173,665'I-pheny 1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'20128,143,411'Substituted 6-phenylnicotinic acids and their use'20127,691,854'Dihydropyridine derivatives for use as human neutrophil elastase inhibitors'20107,687,510'Pyrimidinone derivatives as therapeutic agents against acute and chronic inflammatory, ischaemic and remodelling processes'20107,566,723'1-phenyl1-3,4-dihydropyrimidin-2(1H)-one derivatives and their use'20097,498,460'Isophthalic acid derivatives'20097,230,017'Dihydropyridinone derivatives'2007Career & activity timeline
Assembled from patent assignee/location history and declaration credentials.
2007–2017Based in Oberhausen, DE· patent location history
2012–2017Patents assigned to BAYER IP GMBH (15)· patent assignee history
2012–2019Patents assigned to Bayer Pharma AG (10)· patent assignee history
2012–2013Patents assigned to BAERFACKER LARS (8)· patent assignee history
2012–2015Patents assigned to KOLKHOF PETER (7)· patent assignee history
2012–2013Patents assigned to SCHLEMMER KARL-HEINZ (7)· patent assignee history
2017–2018Based in Düsseldorf, DE· patent location history
2019Based in Dusseldorf, DE· patent location history
Inventor activity
Assignee and location history derived from the patent record.
Assignees
| Assignee | Patents | Span |
|---|---|---|
| BAYER IP GMBH | 15 | 2012–2017 |
| Bayer Pharma AG | 10 | 2012–2019 |
| BAERFACKER LARS | 8 | 2012–2013 |
| KOLKHOF PETER | 7 | 2012–2015 |
| SCHLEMMER KARL-HEINZ | 7 | 2012–2013 |
Locations
| Location | Patents | Span |
|---|---|---|
| Oberhausen, DE | 22 | 2007–2017 |
| Dusseldorf, DE | 3 | 2019 |
| Düsseldorf, DE | 3 | 2017–2018 |